Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
gptkb:Lutetium_Lu_177_dotatate
|
| gptkbp:clinicalTrialPhase |
Phase 1/2
|
| gptkbp:contains |
isotope
peptide cytotoxic payload |
| gptkbp:developedBy |
gptkb:Tarveda_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
PEN-221
|
| gptkbp:mechanismOfAction |
targets somatostatin receptor 2 (SSTR2)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:SSTR2
|
| gptkbp:usedFor |
neuroendocrine tumors
|
| gptkbp:bfsParent |
gptkb:Tarveda_Therapeutics
|
| gptkbp:bfsLayer |
6
|